| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership change | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-04-13 | RA Capital Healthcare Fund LP 10% Owner | Purchase | +223,596 | +23.31%1,182,624 | $7.17 | $1,603,934 | View SEC filing | |
| 2026-04-09 | ORBIMED ADVISORS LLC 10% Owner | Sale | -104,658 | -100.00%0 | $6.45 | $674,847 | View SEC filing | |
| 2025-10-10 | ORBIMED ADVISORS LLC 10% Owner | Purchase | +5,000,000 | -40.34%4,490,254 | $1.00 | $5,000,000 | View SEC filing | |
| 2024-06-07 | Kauffman Michael Director | Sale | -5,900 | -50.00%5,900 | $1.43 | $8,437 | View SEC filing | |
| 2024-01-26 | ORBIMED ADVISORS LLC Director, 10% Owner | Purchase | +3,125,000 | -77.91%1,255,985 | $2.40 | $7,500,000 | View SEC filing | |
| 2024-01-26 | GORDON CARL L Director, 10% Owner | Purchase | +3,125,000 | -77.91%1,255,985 | $2.40 | $7,500,000 | View SEC filing | |
| 2023-10-02 | Schor Chen President & CEO | Mixed | 0 | +0.00%220,438 | $1.38 | $30,440 | View SEC filing | |
| 2023-06-30 | DUBIN STEVE Director | Purchase | +5,000 | +84.75%10,900 | $2.40 | $12,000 | View SEC filing | |
| 2023-06-29 | GORDON CARL L Director, 10% Owner | Purchase | +875,000 | -17.15%748,054 | $2.09 | $1,828,750 | View SEC filing | |
| 2023-06-29 | ORBIMED ADVISORS LLC Director, 10% Owner | Purchase | +875,000 | -17.15%748,054 | $2.09 | $1,828,750 | View SEC filing | |
| 2023-02-17 | Healey Don Chief Technology Officer | Sale | -4,533 | -6.38%66,568 | $7.57 | $34,327 | View SEC filing | |
| 2023-02-14 | Healey Don Chief Technology Officer | Sale | -10,467 | -12.83%71,101 | $7.98 | $83,476 | View SEC filing | |
| 2022-11-15 | Aftab Blake Chief Scientific Officer | Sale | -6,967 | -19.81%28,209 | $21.00 | $146,307 | View SEC filing | |
| 2022-11-15 | Schor Chen President & CEO | Sale | -39,955 | -21.62%144,893 | $20.30 | $811,242 | View SEC filing | |
| 2022-11-09 | Schor Chen President & CEO | Sale | -30,000 | -26.45%83,424 | $19.05 | $571,488 | View SEC filing | |
| 2022-11-04 | Schor Chen President & CEO | Sale | -25,313 | -18.25%113,424 | $18.04 | $456,718 | View SEC filing | |
| 2022-10-21 | Aftab Blake Chief Scientific Officer | Sale | -8,067 | -18.66%35,176 | $16.27 | $131,250 | View SEC filing | |
| 2022-10-14 | Aftab Blake Chief Scientific Officer | Sale | -1,646 | -3.12%51,176 | $15.40 | $25,348 | View SEC filing | |
| 2022-09-16 | Schor Chen President & CEO | Sale | -952 | -0.68%138,737 | $18.00 | $17,136 | View SEC filing | |
| 2022-09-13 | Schor Chen President & CEO | Sale | -78,412 | +86.65%139,689 | $16.80 | $1,317,222 | View SEC filing | |
| 2022-08-05 | Aftab Blake Chief Scientific Officer | Sale | -6,968 | -15.17%38,967 | $18.00 | $125,424 | View SEC filing | |
| 2022-08-03 | Aftab Blake Chief Scientific Officer | Sale | -6,968 | -13.17%45,935 | $16.64 | $115,948 | View SEC filing | |
| 2022-07-07 | Aftab Blake Chief Scientific Officer | Sale | -1,363 | -2.51%52,903 | $14.50 | $19,764 | View SEC filing | |
| 2022-04-05 | Galimi Francesco SVP & Chief Medical Officer | Sale | -15,600 | -11.28%59,917 | $21.00 | $327,600 | View SEC filing | |
| 2022-03-11 | Jakobovits Aya Director | Sale | -4,000 | -0.56%356,345 | $14.00 | $56,000 | View SEC filing |
1-25 of 51
